• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Infect Dis Aberrant Hyperactivation of Cytotoxic T-cell as a Potential Determinant of COVID-19 Severity

tetano

Editor, Senior Moderator
Int J Infect Dis


. 2020 May 31;S1201-9712(20)30413-6.
doi: 10.1016/j.ijid.2020.05.106. Online ahead of print.
Aberrant Hyperactivation of Cytotoxic T-cell as a Potential Determinant of COVID-19 Severity


Chang Kyung Kang[SUP] 1 [/SUP], Gi-Chan Han[SUP] 2 [/SUP], Minji Kim[SUP] 2 [/SUP], Gwanghun Kim[SUP] 2 [/SUP], Hyun Mu Shin[SUP] 3 [/SUP], Kyoung-Ho Song[SUP] 4 [/SUP], Pyoeng Gyun Choe[SUP] 5 [/SUP], Wan Beom Park[SUP] 5 [/SUP], Eu Suk Kim[SUP] 6 [/SUP], Hong Bin Kim[SUP] 6 [/SUP], Nam-Joong Kim[SUP] 5 [/SUP], Hang-Rae Kim[SUP] 7 [/SUP], Myoung-Don Oh[SUP] 8 [/SUP]



Affiliations

Abstract

Objectives: We hypothesized that immune response may contribute to progression of coronavirus disease-19 (COVID-19) at the second week of illness. Therefore, we compared cell-mediated immune (CMI) responses between severe and mild COVID-19 cases.
Methods: We examined peripheral blood mononuclear cells of laboratory-confirmed COVID-19 patients from their first and third weeks of illness. Severe pneumonia was defined as an oxygen saturation ≤ 93% at room air. Expressions of molecules related to T-cell activation and functions were analyzed by flow cytometry.
Results: The population dynamics of T cells at the first week were not different between the two groups. However, total numbers of CD4+ and CD8 + T cells tended to be lower in the severe group at the third week of illness. Expressions of Ki-67, PD-1, perforin, and granzyme B in CD4[SUP]+[/SUP] or CD8[SUP]+[/SUP] T cells were significantly higher in the severe group than in the mild group at the third week. In contrast to the mild group, the levels of their expression did not decrease in severe group.
Conclusions: Severe COVID-19 had higher degree of proliferation, activation, and cytotoxicity of T-cells at the late phase of illness without cytotoxic T-cell contraction, which might contribute to the development of severe COVID-19.

Keywords: COVID-19; contraction; cytotoxic T cell; granzyme B; perforin; severity.
 
Back
Top